Is AMZN Disrupting Healthcare Digitization?

Overall Consensus

As we can see from TipRanks, AMZN is a top Street pick right now. If we look at only ratings from the best-performing analysts we get the following screenshot:

(Click on image to enlarge)

View AMZN Price Target & Analyst Ratings Detail

This shows that in the last three months a whopping 33 top analysts have published AMZN buy ratings. Only one analyst is staying on the sidelines. Meanwhile their average price target of $2,160 speaks of 28% upside for shares from current levels.

However, Mahaney is even more bullish than the average analyst. His buy rating comes with a $2,300 price target. From current levels this indicates shares could surge 36% in the coming months.

“Even though AMZN has consistently traded at a premium valuation level, its sector-leading forward EPS growth outlook and its high EPS quality (very high FCF conversion) warrant, in our opinion, a considerable market multiple premium” he explains.

This is on top of: one of the best management teams on the internet; material margin expansion; new revenue growth opportunities (as well as healthcare we have consumer staples, apparel, international expansion etc); clear market share gains and a path for more of the same; still significant growth for online retail. In other words-AMZN remains a top stock to keep your eye on.

1 2 3
View single page >> |

Disclaimer: TipRanks is an independent cloud based service that measures and ranks digitally published financial advice. TipRanks' natural language processing (NLP) algorithms aggregate and ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.